| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | superoxide-generating NADPH oxidase activator activity | 8.14e-06 | 10 | 83 | 3 | GO:0016176 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 1.32e-05 | 35 | 83 | 4 | GO:0043325 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 1.48e-05 | 12 | 83 | 3 | GO:0016175 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 7.50e-05 | 20 | 83 | 3 | GO:0050664 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.33e-04 | 363 | 83 | 8 | GO:0106310 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 3.13e-04 | 78 | 83 | 4 | GO:0008080 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 5.31e-04 | 446 | 83 | 8 | GO:0004674 | |
| GeneOntologyMolecularFunction | protein kinase activity | 8.55e-04 | 600 | 83 | 9 | GO:0004672 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 8.66e-04 | 102 | 83 | 4 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 9.31e-04 | 104 | 83 | 4 | GO:0016407 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.58e-03 | 120 | 83 | 4 | GO:0008013 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.73e-03 | 15 | 83 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 2.00e-03 | 60 | 83 | 3 | GO:0034212 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of gram-positive bacterium | 6.25e-07 | 5 | 83 | 3 | GO:0070946 | |
| GeneOntologyBiologicalProcess | NADP catabolic process | 2.17e-06 | 7 | 83 | 3 | GO:0006742 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of fungus | 2.17e-06 | 7 | 83 | 3 | GO:0070947 | |
| GeneOntologyBiologicalProcess | regulation of respiratory burst involved in inflammatory response | 1.01e-05 | 11 | 83 | 3 | GO:0060264 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in inflammatory response | 1.75e-05 | 13 | 83 | 3 | GO:0002536 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | RAF1 WASL EPS8L2 LATS1 G3BP1 ABI3BP TJP1 CPEB3 SLITRK5 NEK7 AUTS2 NRG2 CTTN MAP4K4 EP300 ARHGAP33 | 1.79e-05 | 1189 | 83 | 16 | GO:0044087 |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of bacterium | 3.39e-05 | 16 | 83 | 3 | GO:0070944 | |
| GeneOntologyBiologicalProcess | response to yeast | 4.91e-05 | 18 | 83 | 3 | GO:0001878 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of symbiont cell | 5.81e-05 | 19 | 83 | 3 | GO:0070943 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in defense response | 6.82e-05 | 20 | 83 | 3 | GO:0002679 | |
| GeneOntologyBiologicalProcess | neutrophil mediated cytotoxicity | 7.93e-05 | 21 | 83 | 3 | GO:0070942 | |
| GeneOntologyBiologicalProcess | negative regulation of smooth muscle contraction | 9.16e-05 | 22 | 83 | 3 | GO:0045986 | |
| GeneOntologyBiologicalProcess | hydrogen peroxide biosynthetic process | 9.16e-05 | 22 | 83 | 3 | GO:0050665 | |
| GeneOntologyBiologicalProcess | regulation of respiratory burst | 1.05e-04 | 23 | 83 | 3 | GO:0060263 | |
| GeneOntologyBiologicalProcess | biological process involved in interaction with symbiont | 2.15e-04 | 135 | 83 | 5 | GO:0051702 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 2.48e-04 | 309 | 83 | 7 | GO:1901888 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle contraction | 2.91e-04 | 79 | 83 | 4 | GO:0006940 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | RAF1 EPS8L2 LZTR1 G3BP1 ARHGAP10 OBSCN AUTS2 MAP4K4 ARHGAP33 | 3.10e-04 | 538 | 83 | 9 | GO:0007264 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | WASL MAGEL2 LATS1 ABI3BP MICALL2 TJP1 OBSCN AUTS2 NAA80 CTTN EP300 | 3.64e-04 | 803 | 83 | 11 | GO:0030036 |
| GeneOntologyBiologicalProcess | negative regulation of muscle contraction | 3.75e-04 | 35 | 83 | 3 | GO:0045932 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | 3.90e-04 | 333 | 83 | 7 | GO:0051056 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 4.65e-04 | 569 | 83 | 9 | GO:0034329 | |
| GeneOntologyBiologicalProcess | killing by host of symbiont cells | 4.79e-04 | 38 | 83 | 3 | GO:0051873 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 6.00e-04 | 41 | 83 | 3 | GO:0006691 | |
| GeneOntologyCellularComponent | NADPH oxidase complex | 4.55e-05 | 18 | 82 | 3 | GO:0043020 | |
| HumanPheno | Deviation of finger | RAF1 MAGEL2 LZTR1 FBN2 HMGA2 TCF20 COG1 NCF1 AUTS2 EP300 PHF21A | 1.12e-05 | 537 | 24 | 11 | HP:0004097 |
| HumanPheno | Mitral valve prolapse | 1.65e-05 | 123 | 24 | 6 | HP:0001634 | |
| HumanPheno | Deviation of the hand or of fingers of the hand | RAF1 MAGEL2 LZTR1 FBN2 HMGA2 TCF20 COG1 NCF1 AUTS2 EP300 PHF21A | 1.80e-05 | 564 | 24 | 11 | HP:0009484 |
| HumanPheno | Downslanted palpebral fissures | 3.97e-05 | 497 | 24 | 10 | HP:0000494 | |
| HumanPheno | Abnormal mitral valve morphology | 4.39e-05 | 146 | 24 | 6 | HP:0031477 | |
| HumanPheno | Abnormal nasal bridge morphology | RAF1 MAGEL2 LZTR1 HMGA2 TCF20 TCOF1 COG1 NCF1 APC2 MED12L AUTS2 ZMIZ1 EP300 PHF21A | 4.41e-05 | 1029 | 24 | 14 | HP:0000422 |
| HumanPheno | Short attention span | MAGEL2 HMGA2 SATB1 NCF1 APC2 MED12L AUTS2 ZMIZ1 EP300 PHF21A | 5.59e-05 | 517 | 24 | 10 | HP:0000736 |
| HumanPheno | Abnormal curvature of the vertebral column | RAF1 ZNF469 MAGEL2 LZTR1 FBN2 HMGA2 TCF20 SATB1 COG1 NCF1 APC2 MED12L AUTS2 ZMIZ1 EP300 | 6.23e-05 | 1219 | 24 | 15 | HP:0010674 |
| HumanPheno | Reduced attention regulation | MAGEL2 HMGA2 SATB1 NCF1 APC2 MED12L AUTS2 ZMIZ1 EP300 PHF21A | 6.49e-05 | 526 | 24 | 10 | HP:5200044 |
| HumanPheno | Abnormality of mouth size | 7.56e-05 | 425 | 24 | 9 | HP:0011337 | |
| HumanPheno | Abnormal hand morphology | RAF1 MAGEL2 LZTR1 FBN2 HMGA2 TCF20 SATB1 COG1 NCF1 APC2 AUTS2 ZMIZ1 EP300 PHF21A | 7.94e-05 | 1082 | 24 | 14 | HP:0005922 |
| HumanPheno | Hyperactivity | MAGEL2 HMGA2 TCF20 NCF1 APC2 MED12L AUTS2 ZMIZ1 EP300 PHF21A | 1.08e-04 | 558 | 24 | 10 | HP:0000752 |
| HumanPheno | Radial deviation of finger | 1.14e-04 | 448 | 24 | 9 | HP:0009466 | |
| HumanPheno | Brachycephaly | 1.15e-04 | 253 | 24 | 7 | HP:0000248 | |
| HumanPheno | Abnormal mandible morphology | RAF1 MAGEL2 LZTR1 FBN2 HMGA2 TCOF1 COG1 NCF1 APC2 AUTS2 CDC73 ZMIZ1 EP300 PHF21A | 1.16e-04 | 1118 | 24 | 14 | HP:0000277 |
| HumanPheno | Scoliosis | RAF1 ZNF469 MAGEL2 LZTR1 FBN2 HMGA2 TCF20 SATB1 COG1 NCF1 APC2 AUTS2 ZMIZ1 EP300 | 1.21e-04 | 1122 | 24 | 14 | HP:0002650 |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | 1.31e-04 | 456 | 24 | 9 | HP:0009485 | |
| HumanPheno | Abnormality of calvarial morphology | RAF1 MAGEL2 LZTR1 FBN2 HMGA2 TCF20 SATB1 TCOF1 NCF1 APC2 MED12L AUTS2 EP300 PHF21A | 1.37e-04 | 1134 | 24 | 14 | HP:0002648 |
| HumanPheno | Feeding difficulties | RAF1 MAGEL2 LZTR1 HMGA2 SATB1 TCOF1 COG1 OBSCN MED12L AUTS2 CDC73 ZMIZ1 EP300 | 1.41e-04 | 982 | 24 | 13 | HP:0002022 |
| HumanPheno | Abnormal penis morphology | RAF1 MAGEL2 HMGA2 TCOF1 COG1 NCF1 APC2 MED12L ZMIZ1 EP300 PHF21A | 1.62e-04 | 712 | 24 | 11 | HP:0000036 |
| HumanPheno | Constipation | 1.72e-04 | 472 | 24 | 9 | HP:0002019 | |
| HumanPheno | Abnormal male external genitalia morphology | RAF1 MAGEL2 LZTR1 HMGA2 TCOF1 COG1 NCF1 APC2 MED12L AUTS2 COX11 CDC73 ZMIZ1 EP300 PHF21A | 1.81e-04 | 1329 | 24 | 15 | HP:0000032 |
| HumanPheno | Feeding difficulties in infancy | 1.84e-04 | 594 | 24 | 10 | HP:0008872 | |
| HumanPheno | Abnormality of the jaws | RAF1 MAGEL2 LZTR1 FBN2 HMGA2 TCOF1 COG1 NCF1 APC2 AUTS2 CDC73 ZMIZ1 EP300 PHF21A | 2.05e-04 | 1175 | 24 | 14 | HP:0000209 |
| HumanPheno | Abnormal jaw morphology | RAF1 MAGEL2 LZTR1 FBN2 HMGA2 TCOF1 COG1 NCF1 APC2 AUTS2 CDC73 ZMIZ1 EP300 PHF21A | 2.07e-04 | 1176 | 24 | 14 | HP:0030791 |
| HumanPheno | Frontal bossing | RAF1 MAGEL2 LZTR1 FBN2 HMGA2 TCF20 SATB1 TCOF1 NCF1 MED12L EP300 | 2.25e-04 | 738 | 24 | 11 | HP:0002007 |
| HumanPheno | Slanting of the palpebral fissure | RAF1 MAGEL2 LZTR1 SATB1 TCOF1 COG1 APC2 MED12L AUTS2 ZMIZ1 EP300 | 2.28e-04 | 739 | 24 | 11 | HP:0200006 |
| HumanPheno | Abnormality of the palpebral fissures | RAF1 MAGEL2 LZTR1 SATB1 TCOF1 COG1 NCF1 APC2 MED12L AUTS2 ZMIZ1 EP300 | 2.32e-04 | 880 | 24 | 12 | HP:0008050 |
| HumanPheno | Abnormal shape of the frontal region | RAF1 MAGEL2 LZTR1 FBN2 HMGA2 TCF20 SATB1 TCOF1 NCF1 MED12L EP300 | 2.33e-04 | 741 | 24 | 11 | HP:0011218 |
| HumanPheno | Patent ductus arteriosus | 2.34e-04 | 382 | 24 | 8 | HP:0001643 | |
| HumanPheno | Abnormal frontal bone morphology | RAF1 MAGEL2 LZTR1 FBN2 HMGA2 TCF20 SATB1 TCOF1 NCF1 MED12L EP300 | 2.36e-04 | 742 | 24 | 11 | HP:0430000 |
| HumanPheno | Reduced impulse control | CD3E MAGEL2 HMGA2 TCF20 SATB1 NCF1 APC2 MED12L AUTS2 CDC73 ZMIZ1 EP300 PHF21A | 2.39e-04 | 1032 | 24 | 13 | HP:5200045 |
| HumanPheno | Abnormal external genitalia | RAF1 MAGEL2 LZTR1 HMGA2 TCOF1 COG1 NCF1 APC2 MED12L AUTS2 COX11 CDC73 ZMIZ1 EP300 PHF21A | 2.67e-04 | 1372 | 24 | 15 | HP:0000811 |
| HumanPheno | Midface retrusion | 2.75e-04 | 291 | 24 | 7 | HP:0011800 | |
| HumanPheno | Abnormal finger morphology | RAF1 ZNF469 MAGEL2 LZTR1 FBN2 HMGA2 TCF20 COG1 NCF1 APC2 MED12L AUTS2 ZMIZ1 EP300 PHF21A | 2.99e-04 | 1385 | 24 | 15 | HP:0001167 |
| HumanPheno | Wide nasal bridge | 3.02e-04 | 508 | 24 | 9 | HP:0000431 | |
| HumanPheno | Neoplasm of the ear | 3.10e-04 | 29 | 24 | 3 | HP:0012780 | |
| HumanPheno | Abnormal eyelid morphology | RAF1 ZNF469 MAGEL2 LZTR1 TCF20 SATB1 TCOF1 COG1 NCF1 APC2 MED12L AUTS2 ZMIZ1 EP300 PHF21A | 3.64e-04 | 1408 | 24 | 15 | HP:0000492 |
| HumanPheno | Cryptorchidism | RAF1 MAGEL2 LZTR1 HMGA2 TCOF1 COG1 NCF1 APC2 AUTS2 ZMIZ1 EP300 | 3.71e-04 | 780 | 24 | 11 | HP:0000028 |
| HumanPheno | Long fingers | 3.75e-04 | 306 | 24 | 7 | HP:0100807 | |
| HumanPheno | Pulmonic stenosis | 3.81e-04 | 138 | 24 | 5 | HP:0001642 | |
| HumanPheno | Attention deficit hyperactivity disorder | 4.01e-04 | 413 | 24 | 8 | HP:0007018 | |
| HumanPheno | Abnormal lip morphology | RAF1 MAGEL2 LZTR1 HMGA2 TCF20 SATB1 TCOF1 COG1 NCF1 MED12L AUTS2 ZMIZ1 EP300 PHF21A | 4.08e-04 | 1249 | 24 | 14 | HP:0000159 |
| HumanPheno | Macrostomia | 4.24e-04 | 220 | 24 | 6 | HP:0000181 | |
| HumanPheno | Wide mouth | 4.24e-04 | 220 | 24 | 6 | HP:0000154 | |
| HumanPheno | Abnormal calvaria morphology | RAF1 MAGEL2 LZTR1 FBN2 HMGA2 TCF20 SATB1 TCOF1 NCF1 APC2 MED12L AUTS2 EP300 PHF21A | 4.27e-04 | 1254 | 24 | 14 | HP:0002683 |
| HumanPheno | Clinodactyly of the 5th finger | 4.50e-04 | 420 | 24 | 8 | HP:0004209 | |
| HumanPheno | Clinodactyly of hands | 4.58e-04 | 421 | 24 | 8 | HP:0001157 | |
| HumanPheno | Deviation of the 5th finger | 4.58e-04 | 421 | 24 | 8 | HP:0009179 | |
| HumanPheno | Abnormal location of ears | RAF1 MAGEL2 LZTR1 HMGA2 TCF20 SATB1 TCOF1 COG1 NCF1 AUTS2 ZMIZ1 EP300 | 4.64e-04 | 945 | 24 | 12 | HP:0000357 |
| HumanPheno | Abnormality of the male genitalia | RAF1 MAGEL2 LZTR1 HMGA2 TCOF1 COG1 NCF1 APC2 MED12L AUTS2 COX11 CDC73 ZMIZ1 EP300 PHF21A | 4.64e-04 | 1437 | 24 | 15 | HP:0010461 |
| HumanPheno | Osteopenia | 5.03e-04 | 321 | 24 | 7 | HP:0000938 | |
| HumanPheno | Abnormal atrial septum morphology | 5.06e-04 | 544 | 24 | 9 | HP:0011994 | |
| HumanPheno | Pectus excavatum | 5.22e-04 | 323 | 24 | 7 | HP:0000767 | |
| HumanPheno | Autistic behavior | MAGEL2 TCF20 SATB1 NCF1 APC2 MED12L AUTS2 ZMIZ1 EP300 PHF21A | 5.51e-04 | 678 | 24 | 10 | HP:0000729 |
| HumanPheno | Congenital abnormal hair pattern | 5.62e-04 | 327 | 24 | 7 | HP:0011361 | |
| HumanPheno | Uterine leiomyoma | 5.86e-04 | 8 | 24 | 2 | HP:0000131 | |
| HumanPheno | Narrow mouth | 5.90e-04 | 234 | 24 | 6 | HP:0000160 | |
| HumanPheno | Abnormality of bone mineral density | RAF1 ZNF469 MAGEL2 LZTR1 FBN2 HMGA2 TCOF1 COG1 NCF1 CDC73 PHF21A | 5.92e-04 | 822 | 24 | 11 | HP:0004348 |
| HumanPheno | Abnormal testis morphology | RAF1 MAGEL2 LZTR1 HMGA2 TCOF1 COG1 NCF1 APC2 AUTS2 COX11 CDC73 ZMIZ1 EP300 | 6.10e-04 | 1129 | 24 | 13 | HP:0000035 |
| HumanPheno | Abnormal bone ossification | RAF1 ZNF469 MAGEL2 LZTR1 FBN2 HMGA2 TCOF1 COG1 NCF1 CDC73 PHF21A | 6.25e-04 | 827 | 24 | 11 | HP:0011849 |
| HumanPheno | Non-obstructive azoospermia | RAF1 MAGEL2 LZTR1 HMGA2 TCOF1 COG1 NCF1 APC2 AUTS2 COX11 CDC73 ZMIZ1 EP300 | 6.27e-04 | 1132 | 24 | 13 | HP:0011961 |
| HumanPheno | Thick eyebrow | 6.31e-04 | 154 | 24 | 5 | HP:0000574 | |
| HumanPheno | Auditory sensitivity | 6.43e-04 | 37 | 24 | 3 | HP:0025112 | |
| HumanPheno | Abnormal upper lip morphology | MAGEL2 LZTR1 TCF20 SATB1 TCOF1 COG1 NCF1 MED12L AUTS2 ZMIZ1 EP300 PHF21A | 6.58e-04 | 980 | 24 | 12 | HP:0000177 |
| HumanPheno | Deviation of the hallux | 6.79e-04 | 88 | 24 | 4 | HP:0010051 | |
| HumanPheno | Compulsive behaviors | 7.10e-04 | 158 | 24 | 5 | HP:0000722 | |
| HumanPheno | Micrognathia | RAF1 LZTR1 FBN2 HMGA2 TCOF1 COG1 NCF1 AUTS2 ZMIZ1 EP300 PHF21A | 7.40e-04 | 843 | 24 | 11 | HP:0000347 |
| HumanPheno | Finger clinodactyly | 7.40e-04 | 452 | 24 | 8 | HP:0040019 | |
| HumanPheno | Abnormal midface morphology | 7.49e-04 | 704 | 24 | 10 | HP:0000309 | |
| HumanPheno | Palmoplantar cutis laxa | 7.51e-04 | 9 | 24 | 2 | HP:0007517 | |
| HumanPheno | Poor coordination | 7.52e-04 | 39 | 24 | 3 | HP:0002370 | |
| HumanPheno | Clinodactyly | 7.55e-04 | 574 | 24 | 9 | HP:0030084 | |
| HumanPheno | Aplasia/Hypoplasia of the mandible | RAF1 LZTR1 FBN2 HMGA2 TCOF1 COG1 NCF1 AUTS2 ZMIZ1 EP300 PHF21A | 7.55e-04 | 845 | 24 | 11 | HP:0009118 |
| HumanPheno | Azoospermia | RAF1 MAGEL2 LZTR1 HMGA2 TCOF1 COG1 NCF1 APC2 AUTS2 COX11 CDC73 ZMIZ1 EP300 | 7.83e-04 | 1157 | 24 | 13 | HP:0000027 |
| HumanPheno | Abnormality of refraction | 7.93e-04 | 709 | 24 | 10 | HP:0000539 | |
| HumanPheno | Strabismus | RAF1 MAGEL2 LZTR1 TCF20 TCOF1 COG1 NCF1 APC2 MED12L AUTS2 ZMIZ1 EP300 PHF21A | 7.97e-04 | 1159 | 24 | 13 | HP:0000486 |
| HumanPheno | Abnormal pulmonary valve physiology | 8.18e-04 | 163 | 24 | 5 | HP:0031654 | |
| HumanPheno | Feeding difficulties | RAF1 MAGEL2 LZTR1 HMGA2 TCF20 TCOF1 COG1 APC2 MED12L AUTS2 COX11 ZMIZ1 EP300 | 8.62e-04 | 1168 | 24 | 13 | HP:0011968 |
| HumanPheno | Abnormality of the urethra | 8.95e-04 | 465 | 24 | 8 | HP:0000795 | |
| HumanPheno | Abnormality of the philtrum | MAGEL2 LZTR1 SATB1 COG1 NCF1 MED12L AUTS2 ZMIZ1 EP300 PHF21A | 9.59e-04 | 726 | 24 | 10 | HP:0000288 |
| HumanPheno | Posteriorly rotated ears | 9.61e-04 | 470 | 24 | 8 | HP:0000358 | |
| HumanPheno | Abnormally increased volition | MAGEL2 HMGA2 TCF20 SATB1 NCF1 APC2 MED12L AUTS2 ZMIZ1 EP300 PHF21A | 9.65e-04 | 869 | 24 | 11 | HP:5200263 |
| HumanPheno | Abnormal mitral valve morphology | 9.70e-04 | 257 | 24 | 6 | HP:0001633 | |
| HumanPheno | Excessive wrinkled skin | 1.00e-03 | 43 | 24 | 3 | HP:0007392 | |
| HumanPheno | Abnormal spermatogenesis | RAF1 MAGEL2 LZTR1 HMGA2 TCOF1 COG1 NCF1 APC2 AUTS2 COX11 CDC73 ZMIZ1 EP300 | 1.04e-03 | 1190 | 24 | 13 | HP:0008669 |
| HumanPheno | Abnormal bone structure | RAF1 ZNF469 MAGEL2 LZTR1 FBN2 HMGA2 TCOF1 COG1 NCF1 CDC73 PHF21A | 1.09e-03 | 881 | 24 | 11 | HP:0003330 |
| HumanPheno | Intellectual disability, mild | 1.09e-03 | 365 | 24 | 7 | HP:0001256 | |
| HumanPheno | Abnormal conjugate eye movement | RAF1 MAGEL2 LZTR1 TCF20 TCOF1 COG1 NCF1 APC2 MED12L AUTS2 ZMIZ1 EP300 PHF21A | 1.11e-03 | 1198 | 24 | 13 | HP:0000549 |
| HumanPheno | Diagnostic behavioral phenotype | MAGEL2 TCF20 SATB1 NCF1 APC2 MED12L AUTS2 ZMIZ1 EP300 PHF21A | 1.20e-03 | 747 | 24 | 10 | HP:0025783 |
| HumanPheno | Prominent fingertip pads | 1.22e-03 | 46 | 24 | 3 | HP:0001212 | |
| HumanPheno | Epicanthus | 1.24e-03 | 614 | 24 | 9 | HP:0000286 | |
| HumanPheno | Hypospadias | 1.32e-03 | 377 | 24 | 7 | HP:0000047 | |
| HumanPheno | Downturned corners of mouth | 1.35e-03 | 182 | 24 | 5 | HP:0002714 | |
| HumanPheno | Abnormal facial shape | RAF1 MAGEL2 LZTR1 HMGA2 TCF20 TCOF1 COG1 NCF1 APC2 MED12L AUTS2 EP300 PHF21A | 1.35e-03 | 1221 | 24 | 13 | HP:0001999 |
| HumanPheno | Neoplasm of the middle ear | 1.36e-03 | 12 | 24 | 2 | HP:0100799 | |
| HumanPheno | Cholesteatoma | 1.36e-03 | 12 | 24 | 2 | HP:0009797 | |
| HumanPheno | Abnormality of the helix | 1.38e-03 | 183 | 24 | 5 | HP:0000380 | |
| HumanPheno | Prominent digit pad | 1.38e-03 | 48 | 24 | 3 | HP:0011298 | |
| HumanPheno | Aplasia/Hypoplasia involving bones of the skull | RAF1 LZTR1 FBN2 HMGA2 TCOF1 COG1 NCF1 AUTS2 ZMIZ1 EP300 PHF21A | 1.51e-03 | 915 | 24 | 11 | HP:0009116 |
| MousePheno | abnormal angiotensin I-converting enzyme activity | 1.34e-06 | 6 | 58 | 3 | MP:0013254 | |
| MousePheno | increased angiotensin I-converting enzyme activity | 1.34e-06 | 6 | 58 | 3 | MP:0003184 | |
| MousePheno | liver abscess | 2.34e-06 | 7 | 58 | 3 | MP:0003332 | |
| MousePheno | abnormal heart atrium morphology | 4.78e-06 | 232 | 58 | 8 | MP:0003105 | |
| MousePheno | impaired granulocyte bactericidal activity | 7.97e-06 | 10 | 58 | 3 | MP:0005074 | |
| MousePheno | impaired cued conditioning behavior | 2.20e-05 | 82 | 58 | 5 | MP:0009456 | |
| MousePheno | abnormal cardiac muscle contractility | 3.24e-05 | 302 | 58 | 8 | MP:0002972 | |
| MousePheno | increased heart atrium size | 3.82e-05 | 46 | 58 | 4 | MP:0008725 | |
| MousePheno | abnormal vascular endothelial cell physiology | 4.17e-05 | 47 | 58 | 4 | MP:0004003 | |
| MousePheno | prenatal growth retardation | RAF1 CASC3 KLF8 WASL TCF20 G3BP1 TCOF1 TJP1 MIDEAS MAP4K4 INO80D EP300 NPAT | 4.37e-05 | 869 | 58 | 13 | MP:0010865 |
| MousePheno | decreased susceptibility to Orthomyxoviridae infection | 5.29e-05 | 18 | 58 | 3 | MP:0020947 | |
| MousePheno | abnormal heart atrium size | 7.23e-05 | 54 | 58 | 4 | MP:0031576 | |
| MousePheno | decreased vasoconstriction | 9.87e-05 | 22 | 58 | 3 | MP:0003026 | |
| MousePheno | increased circulating renin level | 1.13e-04 | 23 | 58 | 3 | MP:0003352 | |
| MousePheno | abnormal bile duct morphology | 1.41e-04 | 64 | 58 | 4 | MP:0002928 | |
| MousePheno | abnormal anxiety-related response | FBN2 TCF20 CSF2RB ABI3BP NCF1 CPEB3 SLITRK5 AUTS2 CTTN NCF1C NCF1B | 1.97e-04 | 740 | 58 | 11 | MP:0001362 |
| MousePheno | impaired muscle contractility | 2.16e-04 | 297 | 58 | 7 | MP:0000738 | |
| MousePheno | abnormal circulating renin level | 2.29e-04 | 29 | 58 | 3 | MP:0003349 | |
| MousePheno | abnormal muscle contractility | 3.09e-04 | 418 | 58 | 8 | MP:0005620 | |
| MousePheno | abnormal fear/anxiety-related behavior | FBN2 TCF20 CSF2RB PHF20L1 ABI3BP NCF1 CPEB3 SLITRK5 AUTS2 CTTN NCF1C NCF1B | 3.24e-04 | 919 | 58 | 12 | MP:0002065 |
| MousePheno | decreased cranium height | 3.39e-04 | 33 | 58 | 3 | MP:0008525 | |
| MousePheno | abnormal vascular development | 3.62e-04 | 542 | 58 | 9 | MP:0000259 | |
| MousePheno | impaired smooth muscle contractility | 4.04e-04 | 35 | 58 | 3 | MP:0000740 | |
| MousePheno | granulomatous inflammation | 4.39e-04 | 36 | 58 | 3 | MP:0002500 | |
| MousePheno | abnormal cued conditioning behavior | 5.33e-04 | 161 | 58 | 5 | MP:0001454 | |
| MousePheno | skin lesions | 5.45e-04 | 91 | 58 | 4 | MP:0001212 | |
| MousePheno | impaired conditioning behavior | 5.96e-04 | 165 | 58 | 5 | MP:0012317 | |
| MousePheno | abnormal response to cardiac infarction | 6.16e-04 | 94 | 58 | 4 | MP:0000343 | |
| MousePheno | abnormal cell proliferation | RAF1 WASL LZTR1 LATS1 MAST4 SATB1 G3BP1 ABI3BP TCOF1 CPEB3 CDC73 ZMIZ1 DCBLD2 EP300 | 6.55e-04 | 1294 | 58 | 14 | MP:0000350 |
| MousePheno | abnormal cranium size | 6.94e-04 | 97 | 58 | 4 | MP:0010031 | |
| MousePheno | abnormal angiogenesis | 8.35e-04 | 372 | 58 | 7 | MP:0000260 | |
| MousePheno | decreased cranium width | 9.08e-04 | 11 | 58 | 2 | MP:0008526 | |
| Domain | ZnF_C2HC | 2.65e-09 | 55 | 77 | 7 | SM00343 | |
| Domain | Znf_CCHC | 2.65e-09 | 55 | 77 | 7 | IPR001878 | |
| Domain | SH3 | 2.56e-07 | 216 | 77 | 9 | SM00326 | |
| Domain | SH3 | 2.56e-07 | 216 | 77 | 9 | PS50002 | |
| Domain | SH3_domain | 2.99e-07 | 220 | 77 | 9 | IPR001452 | |
| Domain | SH3_1 | 5.93e-05 | 164 | 77 | 6 | PF00018 | |
| Domain | Ser/Thr_kinase_AS | 1.10e-04 | 357 | 77 | 8 | IPR008271 | |
| Domain | S_TKc | 1.14e-04 | 359 | 77 | 8 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 1.21e-04 | 362 | 77 | 8 | PS00108 | |
| Domain | Pkinase | 1.72e-04 | 381 | 77 | 8 | PF00069 | |
| Domain | SH3_9 | 3.02e-04 | 78 | 77 | 4 | PF14604 | |
| Domain | Znf_FYVE_PHD | 3.53e-04 | 147 | 77 | 5 | IPR011011 | |
| Domain | SH3_2 | 4.39e-04 | 86 | 77 | 4 | IPR011511 | |
| Domain | SH3_2 | 4.39e-04 | 86 | 77 | 4 | PF07653 | |
| Domain | PROTEIN_KINASE_ATP | 5.97e-04 | 459 | 77 | 8 | PS00107 | |
| Domain | ZF_PHD_1 | 6.66e-04 | 96 | 77 | 4 | PS01359 | |
| Domain | Prot_kinase_dom | 9.02e-04 | 489 | 77 | 8 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 9.50e-04 | 493 | 77 | 8 | PS50011 | |
| Domain | Kinase-like_dom | 1.73e-03 | 542 | 77 | 8 | IPR011009 | |
| Domain | AT_hook | 1.94e-03 | 16 | 77 | 2 | PF02178 | |
| Domain | Zinc_finger_PHD-type_CS | 2.45e-03 | 65 | 77 | 3 | IPR019786 | |
| Domain | EPHD | 3.67e-03 | 22 | 77 | 2 | PS51805 | |
| Domain | Acetyltransf_1 | 4.01e-03 | 23 | 77 | 2 | PF00583 | |
| Domain | GNAT | 4.73e-03 | 25 | 77 | 2 | PS51186 | |
| Domain | GNAT_dom | 4.73e-03 | 25 | 77 | 2 | IPR000182 | |
| Domain | Bromodomain_CS | 5.11e-03 | 26 | 77 | 2 | IPR018359 | |
| Domain | AT_hook | 5.51e-03 | 27 | 77 | 2 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 5.51e-03 | 27 | 77 | 2 | IPR017956 | |
| Domain | LisH | 5.92e-03 | 28 | 77 | 2 | SM00667 | |
| Domain | LisH | 5.92e-03 | 28 | 77 | 2 | IPR006594 | |
| Domain | LISH | 5.92e-03 | 28 | 77 | 2 | PS50896 | |
| Domain | PHD | 5.93e-03 | 89 | 77 | 3 | SM00249 | |
| Domain | Znf_PHD | 6.31e-03 | 91 | 77 | 3 | IPR001965 | |
| Domain | ZF_PHD_2 | 7.11e-03 | 95 | 77 | 3 | PS50016 | |
| Domain | HMGI/Y_DNA-bd_CS | 7.22e-03 | 31 | 77 | 2 | IPR000637 | |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES | 5.18e-06 | 9 | 57 | 3 | MM14524 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 1.02e-05 | 34 | 57 | 4 | MM1399 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 1.35e-04 | 25 | 57 | 3 | MM15269 | |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A23 FAM90A2P FAM90A1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.38e-25 | 25 | 87 | 12 | 17684299 | |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A23 FAM90A2P FAM90A7 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 6.26e-21 | 23 | 87 | 10 | 18602769 | |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | FAM90A14 FAM90A17 FAM90A19 FAM90A26 FAM90A23 FAM90A1 FAM90A7 FAM90A9 FAM90A8 FAM90A10 | 1.21e-11 | 164 | 87 | 10 | 22967998 |
| Pubmed | 1.82e-10 | 5 | 87 | 4 | 22219181 | ||
| Pubmed | WASL LATS1 TCF20 ABI3BP SH3D19 SREBF2 EVPL MIDEAS MAP4K4 EP300 WNK2 ARHGAP33 | 3.33e-09 | 486 | 87 | 12 | 20936779 | |
| Pubmed | KLF8 FBN2 TCF20 SATB1 GTF3C2 ZFHX4 G3BP1 RBM6 AUTS2 ZC3H18 ZMIZ1 CTTN MIDEAS INO80D EP300 PHF21A HOMEZ NPAT | 1.30e-08 | 1429 | 87 | 18 | 35140242 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 18036262 | ||
| Pubmed | Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice. | 1.51e-08 | 3 | 87 | 3 | 10678931 | |
| Pubmed | Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome. | 1.51e-08 | 3 | 87 | 3 | 27044504 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 17167081 | ||
| Pubmed | Mice lacking NCF1 exhibit reduced growth of implanted melanoma and carcinoma tumors. | 1.51e-08 | 3 | 87 | 3 | 24358335 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 10891396 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 25474113 | ||
| Pubmed | NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. | 1.51e-08 | 3 | 87 | 3 | 18787174 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 26209274 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 24873968 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 22184329 | ||
| Pubmed | NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. | 1.51e-08 | 3 | 87 | 3 | 11018074 | |
| Pubmed | Natural Loss-of-Function Mutations in Qa2 and NCF1 Cause the Spread of Mannan-Induced Psoriasis. | 1.51e-08 | 3 | 87 | 3 | 33545139 | |
| Pubmed | Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis. | 1.51e-08 | 3 | 87 | 3 | 20142487 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 9116268 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 20686129 | ||
| Pubmed | Angiotensin II induced catabolic effect and muscle atrophy are redox dependent. | 1.51e-08 | 3 | 87 | 3 | 21570954 | |
| Pubmed | p47(phox) contributes to albuminuria and kidney fibrosis in mice. | 1.51e-08 | 3 | 87 | 3 | 25565313 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 39357591 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 12958309 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 11435342 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 31118934 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 23482812 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 16041040 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 10085000 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 10987289 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 21435178 | ||
| Pubmed | Intermittent hypoxia has organ-specific effects on oxidative stress. | 1.51e-08 | 3 | 87 | 3 | 18703411 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 29228045 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 17307863 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 22155727 | ||
| Pubmed | Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss. | 1.51e-08 | 3 | 87 | 3 | 27829407 | |
| Pubmed | Mechanism of endoplasmic reticulum stress-induced vascular endothelial dysfunction. | 1.51e-08 | 3 | 87 | 3 | 24576409 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 22376231 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 23918780 | ||
| Pubmed | NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells. | 1.51e-08 | 3 | 87 | 3 | 28274989 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 26645958 | ||
| Pubmed | Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. | 1.51e-08 | 3 | 87 | 3 | 12364355 | |
| Pubmed | NADPH oxidase promotes neutrophil extracellular trap formation in pulmonary aspergillosis. | 1.51e-08 | 3 | 87 | 3 | 24549323 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 34557202 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 28467721 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 10670582 | ||
| Pubmed | NADPH oxidase deficiency regulates Th lineage commitment and modulates autoimmunity. | 1.51e-08 | 3 | 87 | 3 | 20881184 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 26528554 | ||
| Pubmed | The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis. | 1.51e-08 | 3 | 87 | 3 | 19052348 | |
| Pubmed | Effect of early particulate air pollution exposure on obesity in mice: role of p47phox. | 1.51e-08 | 3 | 87 | 3 | 20864666 | |
| Pubmed | Reactive oxygen species delay control of lymphocytic choriomeningitis virus. | 1.51e-08 | 3 | 87 | 3 | 23328631 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 34572995 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 17114280 | ||
| Pubmed | Participation of mitochondrial respiratory complex III in neutrophil activation and lung injury. | 1.51e-08 | 3 | 87 | 3 | 19168575 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 25989352 | ||
| Pubmed | NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. | 1.51e-08 | 3 | 87 | 3 | 19503084 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 17404617 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 17332431 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 36592568 | ||
| Pubmed | Genetic requirement of p47phox for superoxide production by murine microglia. | 1.51e-08 | 3 | 87 | 3 | 11156938 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 30504842 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 10772875 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 27798190 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 20702812 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 33705493 | ||
| Pubmed | Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis. | 1.51e-08 | 3 | 87 | 3 | 23965970 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 26455429 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 15513930 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 15626477 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 15033459 | ||
| Pubmed | NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity. | 1.51e-08 | 3 | 87 | 3 | 19077231 | |
| Pubmed | Neutrophil-derived ROS contribute to oxidative DNA damage induction by quartz particles. | 1.51e-08 | 3 | 87 | 3 | 20828610 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 20817944 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 22319452 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 16895801 | ||
| Pubmed | Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis. | 1.51e-08 | 3 | 87 | 3 | 20690191 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 16772302 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 32504071 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 16280459 | ||
| Pubmed | Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. | 1.51e-08 | 3 | 87 | 3 | 18185592 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 36853827 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 23024271 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 21253614 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 25873172 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 15310853 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 31393787 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 10725280 | ||
| Pubmed | Ncf1 Governs Immune Niches in the Lung to Mediate Pulmonary Inflammation in Mice. | 1.51e-08 | 3 | 87 | 3 | 34970267 | |
| Pubmed | Germ-free mice deficient of reactive oxygen species have increased arthritis susceptibility. | 1.51e-08 | 3 | 87 | 3 | 25689796 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 14993144 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 22050439 | ||
| Pubmed | The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. | 1.51e-08 | 3 | 87 | 3 | 12031896 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 11249873 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 15936744 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 17220182 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 25628043 | ||
| Pubmed | The p47phox mouse knock-out model of chronic granulomatous disease. | 1.51e-08 | 3 | 87 | 3 | 7650482 | |
| Pubmed | Disseminated trichosporonosis in a murine model of chronic granulomatous disease. | 1.51e-08 | 3 | 87 | 3 | 12868577 | |
| Interaction | FEV interactions | 7.87e-07 | 203 | 74 | 8 | int:FEV | |
| Interaction | CSNK2A2 interactions | RAF1 BRPF3 IL16 LATS1 HMGA2 TCF20 G3BP1 TCOF1 NCF1 AUTS2 ZC3H18 FAM90A1 EP300 | 1.89e-06 | 718 | 74 | 13 | int:CSNK2A2 |
| Interaction | ACTN3 interactions | 2.99e-06 | 109 | 74 | 6 | int:ACTN3 | |
| Interaction | TLX1 interactions | 3.64e-06 | 175 | 74 | 7 | int:TLX1 | |
| Interaction | TBXT interactions | 4.30e-06 | 116 | 74 | 6 | int:TBXT | |
| Interaction | PAX9 interactions | 8.30e-06 | 130 | 74 | 6 | int:PAX9 | |
| Interaction | FAM90A26 interactions | 1.33e-05 | 2 | 74 | 2 | int:FAM90A26 | |
| Interaction | SP7 interactions | 1.55e-05 | 304 | 74 | 8 | int:SP7 | |
| Interaction | PIAS3 interactions | 2.61e-05 | 95 | 74 | 5 | int:PIAS3 | |
| Interaction | MYH13 interactions | 2.88e-05 | 48 | 74 | 4 | int:MYH13 | |
| Interaction | LUC7L interactions | 3.00e-05 | 242 | 74 | 7 | int:LUC7L | |
| Interaction | KDM1A interactions | RAF1 IL16 TCF20 SATB1 GTF3C2 ZFHX4 PHF20L1 SH3D19 ZMIZ1 EP300 PHF21A HOMEZ NPAT | 3.42e-05 | 941 | 74 | 13 | int:KDM1A |
| Interaction | DVL2 interactions | 3.52e-05 | 557 | 74 | 10 | int:DVL2 | |
| Interaction | MEAF6 interactions | 4.03e-05 | 104 | 74 | 5 | int:MEAF6 | |
| Interaction | CRX interactions | 4.08e-05 | 254 | 74 | 7 | int:CRX | |
| Interaction | TBR1 interactions | 6.00e-05 | 113 | 74 | 5 | int:TBR1 | |
| Interaction | CLTB interactions | 6.09e-05 | 185 | 74 | 6 | int:CLTB | |
| Interaction | BOLA2 interactions | 6.80e-05 | 116 | 74 | 5 | int:BOLA2 | |
| Interaction | HDAC2 interactions | RAF1 KLF8 TCF20 SATB1 PHF20L1 G3BP1 NEK7 ZC3H18 CDC73 MIDEAS EP300 PHF21A | 6.84e-05 | 865 | 74 | 12 | int:HDAC2 |
| Interaction | GOLGA2 interactions | RAF1 IL16 LZTR1 LATS1 TCF20 COG1 CCDC87 CCDC187 CDC73 FAM90A1 EP300 | 7.08e-05 | 733 | 74 | 11 | int:GOLGA2 |
| Interaction | LGALS4 interactions | 7.98e-05 | 23 | 74 | 3 | int:LGALS4 | |
| Interaction | ANXA6 interactions | 8.31e-05 | 121 | 74 | 5 | int:ANXA6 | |
| Interaction | PAX7 interactions | 9.33e-05 | 124 | 74 | 5 | int:PAX7 | |
| Interaction | DCD interactions | 9.90e-05 | 202 | 74 | 6 | int:DCD | |
| Interaction | PFN1 interactions | 1.00e-04 | 509 | 74 | 9 | int:PFN1 | |
| Interaction | TRIM27 interactions | BRPF3 IL16 MAGEL2 MYO15B TCF20 CCDC87 CCDC187 FAM90A1 MIDEAS | 1.08e-04 | 514 | 74 | 9 | int:TRIM27 |
| Interaction | RBM26 interactions | 1.17e-04 | 130 | 74 | 5 | int:RBM26 | |
| Interaction | AMOT interactions | 1.48e-04 | 312 | 74 | 7 | int:AMOT | |
| Interaction | WWTR1 interactions | 1.56e-04 | 422 | 74 | 8 | int:WWTR1 | |
| Interaction | BICD2 interactions | 1.66e-04 | 426 | 74 | 8 | int:BICD2 | |
| Interaction | YWHAH interactions | RAF1 CASC3 PDE3B LATS1 MAST4 TCF20 G3BP1 TJP1 SH3D19 AAK1 MAP4K4 WNK2 HOMEZ | 1.69e-04 | 1102 | 74 | 13 | int:YWHAH |
| Interaction | GAPDH interactions | RAF1 CASC3 MAGEL2 G3BP1 MICALL2 OBSCN ZC3H18 CDC73 EP300 NPAT | 1.97e-04 | 686 | 74 | 10 | int:GAPDH |
| Interaction | PTBP1 interactions | 1.98e-04 | 437 | 74 | 8 | int:PTBP1 | |
| Interaction | ZYX interactions | 2.04e-04 | 329 | 74 | 7 | int:ZYX | |
| Interaction | SFN interactions | 2.11e-04 | 692 | 74 | 10 | int:SFN | |
| Interaction | SOX7 interactions | 2.36e-04 | 82 | 74 | 4 | int:SOX7 | |
| Interaction | SRRT interactions | 2.50e-04 | 340 | 74 | 7 | int:SRRT | |
| Interaction | AKAP8L interactions | 2.52e-04 | 240 | 74 | 6 | int:AKAP8L | |
| Interaction | STAT1 interactions | 2.59e-04 | 342 | 74 | 7 | int:STAT1 | |
| Interaction | EYA4 interactions | 2.70e-04 | 243 | 74 | 6 | int:EYA4 | |
| Interaction | LCK interactions | 2.92e-04 | 463 | 74 | 8 | int:LCK | |
| Interaction | GSC interactions | 2.96e-04 | 87 | 74 | 4 | int:GSC | |
| Interaction | LARP1 interactions | 3.01e-04 | 465 | 74 | 8 | int:LARP1 | |
| Interaction | SOX5 interactions | 3.25e-04 | 162 | 74 | 5 | int:SOX5 | |
| Interaction | KIFC3 interactions | 3.28e-04 | 252 | 74 | 6 | int:KIFC3 | |
| Interaction | CPSF1 interactions | 3.49e-04 | 255 | 74 | 6 | int:CPSF1 | |
| Interaction | ERAS interactions | 3.67e-04 | 8 | 74 | 2 | int:ERAS | |
| Interaction | ZNF469 interactions | 3.67e-04 | 8 | 74 | 2 | int:ZNF469 | |
| Interaction | RERE interactions | 3.82e-04 | 93 | 74 | 4 | int:RERE | |
| Interaction | HMGN1 interactions | 3.84e-04 | 168 | 74 | 5 | int:HMGN1 | |
| Interaction | PAX6 interactions | 3.90e-04 | 366 | 74 | 7 | int:PAX6 | |
| Interaction | KHDRBS3 interactions | 3.98e-04 | 94 | 74 | 4 | int:KHDRBS3 | |
| Interaction | NUDT21 interactions | 4.09e-04 | 369 | 74 | 7 | int:NUDT21 | |
| Interaction | PHF5A interactions | 4.17e-04 | 171 | 74 | 5 | int:PHF5A | |
| Interaction | EGR2 interactions | 4.17e-04 | 171 | 74 | 5 | int:EGR2 | |
| Interaction | AKT1 interactions | 4.18e-04 | 617 | 74 | 9 | int:AKT1 | |
| Interaction | ACTA1 interactions | 4.23e-04 | 371 | 74 | 7 | int:ACTA1 | |
| Interaction | DPM1 interactions | 4.39e-04 | 173 | 74 | 5 | int:DPM1 | |
| Interaction | DMPK interactions | 4.58e-04 | 41 | 74 | 3 | int:DMPK | |
| Interaction | CSNK2B interactions | 4.59e-04 | 625 | 74 | 9 | int:CSNK2B | |
| Interaction | PCNA interactions | 4.68e-04 | 497 | 74 | 8 | int:PCNA | |
| Interaction | NCF1C interactions | 4.71e-04 | 9 | 74 | 2 | int:NCF1C | |
| Interaction | TEAD1 interactions | 4.75e-04 | 176 | 74 | 5 | int:TEAD1 | |
| Interaction | SNRNP40 interactions | 5.27e-04 | 637 | 74 | 9 | int:SNRNP40 | |
| Interaction | GABPB1 interactions | 5.28e-04 | 43 | 74 | 3 | int:GABPB1 | |
| Interaction | RBBP7 interactions | 5.34e-04 | 507 | 74 | 8 | int:RBBP7 | |
| Interaction | ZMIZ1 interactions | 5.65e-04 | 44 | 74 | 3 | int:ZMIZ1 | |
| Interaction | MYBPC1 interactions | 5.65e-04 | 44 | 74 | 3 | int:MYBPC1 | |
| Interaction | H1-10 interactions | 5.73e-04 | 280 | 74 | 6 | int:H1-10 | |
| Interaction | MAPRE1 interactions | 5.84e-04 | 514 | 74 | 8 | int:MAPRE1 | |
| Cytoband | 8p23.1 | FAM90A14 FAM90A17 FAM90A19 FAM90A23 FAM90A2P FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 9.47e-15 | 154 | 87 | 11 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A14 FAM90A17 FAM90A19 FAM90A23 FAM90A2P FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 9.49e-13 | 234 | 87 | 11 | chr8p23 |
| Cytoband | 7q11.23 | 8.52e-04 | 97 | 87 | 3 | 7q11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | 1.80e-03 | 271 | 87 | 4 | chr7q11 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 8.00e-04 | 15 | 51 | 2 | 529 | |
| GeneFamily | GCN5 related N-acetyltransferases | 2.07e-03 | 24 | 51 | 2 | 1134 | |
| GeneFamily | PHD finger proteins | 2.09e-03 | 90 | 51 | 3 | 88 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.51e-08 | 199 | 77 | 7 | 5a1557fe35aa48080d4967e8724bf27f9585a5fb | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.51e-08 | 199 | 77 | 7 | 0a657475b92aa3a713da62da364525249fdc3886 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.51e-08 | 199 | 77 | 7 | a8f4bd0e65f36b29535864fae4347369d5c864d2 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.51e-08 | 199 | 77 | 7 | eacea42e973f073b410f54c0a1b3a7f2dc2b5a29 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.78e-07 | 183 | 77 | 6 | f478dfa231fc1b12ead0183cc9d22077cdf43d1f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.03e-07 | 184 | 77 | 6 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | NS-critical-d_0-4-Lymphoid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.69e-07 | 190 | 77 | 6 | 84f9f5ac29ff0f929a589b76efa61d4c570e76b0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-06 | 192 | 77 | 6 | 1c0ce299cee9ab5cdea256f3e8c1e5598577a8b6 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-06 | 198 | 77 | 6 | fb3965049cb1961de0d2e74370868e46aa5050c8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-06 | 198 | 77 | 6 | 72d91bd0c727ecadc41e023a16c9326158db1b7b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-06 | 198 | 77 | 6 | 441608034c787e55691558a480dcd07e37419138 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-06 | 198 | 77 | 6 | 9f5726aedd1fb132feab717a029fa302306461b5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.31e-06 | 200 | 77 | 6 | 6b7314c425f6b40f1301dd39cc02b0436e96a2ec | |
| ToppCell | Healthy/Control-CD8+_T_naive|World / Disease group and Cell class | 8.08e-06 | 158 | 77 | 5 | 70680b29428b6bf882b1fae36f924b775961176b | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like-MAIT|blood / Manually curated celltypes from each tissue | 1.32e-05 | 175 | 77 | 5 | b4e4b66e89f79999768a6192c8404cb2465f920b | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 178 | 77 | 5 | a9a8567d8fdc0fffd612fee16b5b29ef7b1c9307 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 178 | 77 | 5 | 5ecbea15efd304057aef826ec2f385997bfaf0c9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.44e-05 | 178 | 77 | 5 | 31c847d7f7aa0f6d820afbb45d507992f5e9dc2f | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK-CD8_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.48e-05 | 179 | 77 | 5 | 4e9e0deabf9b09ffcf30fed6d5eae72ce0ef2f1f | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 1.56e-05 | 181 | 77 | 5 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-Progen-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.56e-05 | 181 | 77 | 5 | 55fcefa234c8fc707b23248e724756d69827cd18 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T8_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.60e-05 | 182 | 77 | 5 | 3a3ed195c15d33d46a2f395cb93018e4bba28353 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-05 | 183 | 77 | 5 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | remission-CD8+_T_naive|World / disease stage, cell group and cell class | 1.73e-05 | 185 | 77 | 5 | 69304d7dd406ac7e96d51c239d7035a06d88704f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.78e-05 | 186 | 77 | 5 | c793a3d5709ad504c12fc3b2337746d90236d3ca | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-Progen|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.82e-05 | 187 | 77 | 5 | 16fffe894a2c7d5186556ad000e0be229511fbdb | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.87e-05 | 188 | 77 | 5 | 88b808561ebde997ac8a8bbd1d9bbda49bbb6646 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.87e-05 | 188 | 77 | 5 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.92e-05 | 189 | 77 | 5 | fb7572fb4c7c43886d57a025decad076f32a14c4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.92e-05 | 189 | 77 | 5 | e9df7ecd36bee1fedce23bb188c68a94fa60462c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-SELL+_CD8_T|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-05 | 189 | 77 | 5 | e9f66bf288aac04602206f058f5b7af75b1ffdab | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.02e-05 | 191 | 77 | 5 | 9bb6a6b88f351217455765ba07a6acf11fda98f4 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.02e-05 | 191 | 77 | 5 | f398344aaa79fc93d792e241b634a6afe4aff33d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.02e-05 | 191 | 77 | 5 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.02e-05 | 191 | 77 | 5 | 11da47d96f44ba629e3299667495e7daddbbe86c | |
| ToppCell | severe_COVID-19-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 2.02e-05 | 191 | 77 | 5 | 55a282478488efd1561ea57a6f0218f55f711bb0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.02e-05 | 191 | 77 | 5 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | COVID-19_Moderate-CD8+_T_naive|World / disease group, cell group and cell class | 2.02e-05 | 191 | 77 | 5 | c3385226915097f47d2f197166fc755227438524 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.02e-05 | 191 | 77 | 5 | ffcb2c8dbcf40281b439f4b719b5b341972ffb9a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.02e-05 | 191 | 77 | 5 | fda432a7f79664e8ffd5d03c1c69ec43bbac994b | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.02e-05 | 191 | 77 | 5 | ffe88d1ad676c745c76db89f766062fd365329f4 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-Treg|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.07e-05 | 192 | 77 | 5 | cd34defac6565d34db507918e791b09c79f7d1f8 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.07e-05 | 192 | 77 | 5 | ef8970e5389bd55c1624cd6dd01a7ca7abaa8950 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-CD4+_T_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 2.07e-05 | 192 | 77 | 5 | ad7207810116e73d461242e42071901b6a9f48c6 | |
| ToppCell | remission-CD4+_T_naive|remission / disease stage, cell group and cell class | 2.07e-05 | 192 | 77 | 5 | d96b2122e28c735d8002ad6eb2d3d52c8e9ccf2b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.12e-05 | 193 | 77 | 5 | 95f5611dd9583f339b7c9f52bb478af204fb89ad | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 193 | 77 | 5 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | CF-Epithelial|CF / Disease state, Lineage and Cell class | 2.12e-05 | 193 | 77 | 5 | 518901c2e36a79c6189cd0d9e6d36dbd4f56a79c | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_naive|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.12e-05 | 193 | 77 | 5 | 2946e8c9328e356cda3dafe7c86e8de462df37da | |
| ToppCell | CF-Epithelial-Epithelial_cell|CF / Disease state, Lineage and Cell class | 2.12e-05 | 193 | 77 | 5 | 4e3dda27c71b7fdac90d081f0d8e9ca3a8ea7820 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_naive-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.12e-05 | 193 | 77 | 5 | 1559d25b3f1c4ea268478ac26ba13f166b96f1dc | |
| ToppCell | Healthy_donor-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 2.17e-05 | 194 | 77 | 5 | bcaaa6b6ce5b3552f11311d8ee91c35b8ec065f8 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.17e-05 | 194 | 77 | 5 | 2e2019a7bf57f257f0ff9b24eacff59dbb952ebb | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.17e-05 | 194 | 77 | 5 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.17e-05 | 194 | 77 | 5 | d788d5bd1e651706e7e2d54ada546a5e84f86ff0 | |
| ToppCell | severe_COVID-19-CD4+_T_naive|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.17e-05 | 194 | 77 | 5 | 4b86f3cc173ea779399d5b3598b45b25f60a4395 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.17e-05 | 194 | 77 | 5 | e0ccf18edbae09fc1068f1e923f1bc0d0ff44195 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.17e-05 | 194 | 77 | 5 | fc0504730ae576ff46ba0bc9f585c53ab78d914c | |
| ToppCell | Control-Lymphoid_T/NK-CD4+_T_naive|Control / Disease group, lineage and cell class | 2.17e-05 | 194 | 77 | 5 | aabcd9f71d8ef54add5c46d8a3e226e3ae3ab124 | |
| ToppCell | critical-Lymphoid-Treg|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.17e-05 | 194 | 77 | 5 | deaae292972371b6afae58a023fe2fc05b351bda | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.23e-05 | 195 | 77 | 5 | 146e482f660c0f234a3d15495ad9e7ed7b88fdc8 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.23e-05 | 195 | 77 | 5 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Naive_CD4+_T|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.23e-05 | 195 | 77 | 5 | c72943618ced6797202894f78fbb8f300c2e4387 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.23e-05 | 195 | 77 | 5 | efc71886b8521539dcba9d5c1a8304eec2dc6c42 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.23e-05 | 195 | 77 | 5 | 9c71d2a58e772b556e22e2f1d60593580b7aafd8 | |
| ToppCell | COVID-19_Moderate-CD8+_T_naive|COVID-19_Moderate / disease group, cell group and cell class | 2.23e-05 | 195 | 77 | 5 | 22fdc8876883c6b00049ed978260e11f02209b3a | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.28e-05 | 196 | 77 | 5 | a6fcd4f9a39f8e4ff3076735dd615311104dfd1d | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Naive_CD4+_T|normal_Lymph_Node / Location, Cell class and cell subclass | 2.34e-05 | 197 | 77 | 5 | a25954c534da16d5ce57cfe3a3a01beb2f556a5c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_naive|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.34e-05 | 197 | 77 | 5 | 9373fcd728016b7af1abd7d88c47b7db79eb6a2f | |
| ToppCell | IIF-Lymphocyte-T_NK-CD8_Naive|IIF / Disease, Lineage and Cell Type | 2.34e-05 | 197 | 77 | 5 | fa376bde80ed0ae57ae064ff7165cfb870724b93 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-SELL+_CD8_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-05 | 198 | 77 | 5 | 0dac00a64fe08ec6669af3ddd4b82413b673233d | |
| ToppCell | NS-critical-LOC-Lymphoid-CTL|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.40e-05 | 198 | 77 | 5 | e2acb074142aa62c763139bbcf36f6f85038d04b | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.40e-05 | 198 | 77 | 5 | 67e297b3f305d136ff586f68b618e25c902dbcb7 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_naive-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.40e-05 | 198 | 77 | 5 | 239bef79ebaa6e1d8618c670c1050a02362058ee | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.40e-05 | 198 | 77 | 5 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.40e-05 | 198 | 77 | 5 | cb177bad587de804f98b38502a284dc267e37aff | |
| ToppCell | 21-Trachea-Immune-Hematopoietic,_T_Cells|Trachea / Age, Tissue, Lineage and Cell class | 2.40e-05 | 198 | 77 | 5 | da32693a9833ffeced87fe6ec91f076648005f6d | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T8_naive|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.46e-05 | 199 | 77 | 5 | 40eb207fa0f07e2e4d0be69530b8f61f7ea49c73 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-05 | 199 | 77 | 5 | b01328a80db5bb088c44564cea0f6729b1a9805b | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-T8_naive-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.46e-05 | 199 | 77 | 5 | fd989d9088646b3ffda9c5c9c920048f98934e07 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T8_naive-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.46e-05 | 199 | 77 | 5 | 67b9ff07de5be0895612c201cb21e66a3f88669a | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T8_naive|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.46e-05 | 199 | 77 | 5 | e47f8314a4822bf00d0999316457f95c338585e1 | |
| ToppCell | control-CD8+_T_naive|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.46e-05 | 199 | 77 | 5 | 6a61ce7404c65e506091fee99a2001f5a9b39f31 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-T8_naive|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.46e-05 | 199 | 77 | 5 | 8a89d6d824f8ac5929cfabd00e63811cecb97eab | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.46e-05 | 199 | 77 | 5 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| ToppCell | mLN-(1)_T_cell-(14)_Tcm|mLN / shred on region, Cell_type, and subtype | 2.46e-05 | 199 | 77 | 5 | 3222454da504e119c78e666b90cc669ff0335b1a | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-05 | 199 | 77 | 5 | 45d0d275ffb4183e3e71f4701e121ef9853ebd10 | |
| ToppCell | mLN-T_cell-Tcm|mLN / Region, Cell class and subclass | 2.46e-05 | 199 | 77 | 5 | b1237c8d1acad6737d8cb425dc4eb50724e2302c | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T8_naive-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.46e-05 | 199 | 77 | 5 | 6ed413872301707dc73ae66365bee94cd38a292c | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_naive|Control / Disease, condition lineage and cell class | 2.52e-05 | 200 | 77 | 5 | 59b446cd886767f19553aed779ab313685789f6f | |
| ToppCell | control-MAIT|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.52e-05 | 200 | 77 | 5 | aeea4bda2e38cc6db571ed2b47ce022d637619bd | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-CD4+_T_naive|COVID-19_Convalescent / Disease, condition lineage and cell class | 2.52e-05 | 200 | 77 | 5 | 729873094526b7752b91470f4a7281af7d57dbf9 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-CD8+_T_naive|IIF / Disease, condition lineage and cell class | 2.52e-05 | 200 | 77 | 5 | 350b189d0baca9516375786c3712c76c6b4fb390 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_T_naive|Control / Disease, condition lineage and cell class | 2.52e-05 | 200 | 77 | 5 | 906de95adc9716982ab32f216dddeb52639bad06 | |
| ToppCell | control-CD4+_T_naive|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.52e-05 | 200 | 77 | 5 | 0adb8dc3188c07a4871c6d524aab8f45dff0b14e | |
| ToppCell | Control-Control-Lymphocyte-T/NK-gd_T|Control / Disease, condition lineage and cell class | 2.52e-05 | 200 | 77 | 5 | 88e502c141bbb73e62aa5830d24bd645376e5f3a | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-CD8+_T_naive|COVID-19_Convalescent / Disease, condition lineage and cell class | 2.52e-05 | 200 | 77 | 5 | 65ae349fac4084faacbc6a645a92398f6324770e | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.52e-05 | 200 | 77 | 5 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Tnaive/CM_CD4|lymph-node_spleen / Manually curated celltypes from each tissue | 2.52e-05 | 200 | 77 | 5 | 39d60ec4b125b4ff905a2c6a0f2d6923b8d64227 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic-immature_natural_killer_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.20e-04 | 146 | 77 | 4 | 40fac8a298152ec7f7eeeed5a2d28541aea3b338 | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 1.39e-07 | 5 | 72 | 3 | DOID:3265 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 3.02e-06 | 12 | 72 | 3 | DOID:7148 (implicated_via_orthology) | |
| Disease | insomnia measurement | 1.04e-04 | 443 | 72 | 7 | EFO_0007876 | |
| Disease | Abnormality of the skeletal system | 1.63e-04 | 8 | 72 | 2 | C4021790 | |
| Disease | Noonan syndrome (is_implicated_in) | 1.63e-04 | 8 | 72 | 2 | DOID:3490 (is_implicated_in) | |
| Disease | body surface area | 1.71e-04 | 643 | 72 | 8 | EFO_0022196 | |
| Disease | response to tamoxifen | 2.09e-04 | 9 | 72 | 2 | EFO_0009391 | |
| Disease | Noonan syndrome | 2.09e-04 | 9 | 72 | 2 | cv:C0028326 | |
| Disease | testosterone measurement | RAF1 CASC3 KLF8 FBN2 ADO GTF3C2 ZFHX4 ARHGAP10 AUTS2 ZMIZ1 MIDEAS | 2.52e-04 | 1275 | 72 | 11 | EFO_0004908 |
| Disease | RASopathy | 6.04e-04 | 15 | 72 | 2 | cv:C5555857 | |
| Disease | C-reactive protein measurement | ZNF469 LATS1 GTF3C2 ARHGAP10 NCF1 NEK7 ZMIZ1 MAP4K4 PHF21A ARHGAP33 | 6.71e-04 | 1206 | 72 | 10 | EFO_0004458 |
| Disease | Cardiovascular Abnormalities | 6.89e-04 | 16 | 72 | 2 | C0243050 | |
| Disease | hair colour measurement | 7.54e-04 | 615 | 72 | 7 | EFO_0007822 | |
| Disease | Intellectual Disability | 7.85e-04 | 447 | 72 | 6 | C3714756 | |
| Disease | central corneal thickness | 9.62e-04 | 309 | 72 | 5 | EFO_0005213 | |
| Disease | urinary albumin to creatinine ratio | 9.77e-04 | 179 | 72 | 4 | EFO_0007778 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 9.77e-04 | 19 | 72 | 2 | C3501846 | |
| Disease | Costello syndrome (disorder) | 9.77e-04 | 19 | 72 | 2 | C0587248 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 9.77e-04 | 19 | 72 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 9.77e-04 | 19 | 72 | 2 | C1275081 | |
| Disease | LEOPARD Syndrome | 1.31e-03 | 22 | 72 | 2 | C0175704 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.34e-03 | 195 | 72 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Ovarian Serous Adenocarcinoma | 1.44e-03 | 23 | 72 | 2 | C1335177 | |
| Disease | cortical surface area measurement | 1.53e-03 | 1345 | 72 | 10 | EFO_0010736 | |
| Disease | Noonan Syndrome | 1.57e-03 | 24 | 72 | 2 | C0028326 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.64e-03 | 206 | 72 | 4 | C0152013 | |
| Disease | pulse pressure measurement | 1.97e-03 | 1392 | 72 | 10 | EFO_0005763 | |
| Disease | gamma-glutamyltyrosine measurement | 1.98e-03 | 27 | 72 | 2 | EFO_0021144 | |
| Disease | free androgen index | 2.22e-03 | 374 | 72 | 5 | EFO_0007005 | |
| Disease | corneal topography | 2.43e-03 | 109 | 72 | 3 | EFO_0004345 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QVRSPQPVPSPRPQS | 2306 | Q09472 | |
| RPGSPPEKRSPFPQQ | 516 | A0A096LP49 | |
| AAQPVPRPVSQARPP | 336 | Q6P1J9 | |
| PRPVSQARPPPNQKK | 341 | Q6P1J9 | |
| QARPPPNQKKGSRTP | 346 | Q6P1J9 | |
| PVRQQPKVQTTPPPA | 596 | Q2M2I8 | |
| RKATLQPLPPNLPPV | 71 | Q96SZ5 | |
| NALRQKLAQPPPPQP | 776 | Q9ULD4 | |
| PTRTTSPEPQKRPPQ | 26 | Q9NVE4 | |
| QKQRRAPVGPRAPPP | 21 | A6NDY2 | |
| SQPKTPVPAQRERAP | 306 | P04049 | |
| QKQRRAPVGPRSPPP | 21 | A6NKC0 | |
| PVCNRSIPQFPVPPK | 976 | Q14207 | |
| SPPNAPPRQSKRQGQ | 591 | A1A4S6 | |
| QKQRRAPVGPRSPPP | 21 | A8MXZ1 | |
| SQQPPPPQQERSKPS | 536 | O95819 | |
| SVPLPQDPMRPRQPQ | 2041 | Q86YW9 | |
| RKQQPPPRTPLDQPV | 631 | Q8N653 | |
| PPVIRQAPPVIRQAP | 441 | Q9UJ55 | |
| PPVIRQAPPVIRQAP | 476 | Q9UJ55 | |
| PPLRQAPQARLPAPQ | 521 | Q9UJ55 | |
| QVRSVTPPPPPRGQT | 241 | O95835 | |
| PSPRPPRKAPNLTAQ | 216 | Q93015 | |
| QKQRRAPVGPRAPPP | 21 | Q86YD7 | |
| PARKPPLSPAQTNPV | 146 | Q8IY33 | |
| QKQRRAPVGPRAPPP | 21 | P0C7W9 | |
| NVELRPPPASPQQPR | 56 | Q13370 | |
| PPVPQFQPQKALRPD | 11 | Q8TDX7 | |
| TQRSKPQPAVPPRPS | 356 | P14598 | |
| SQEAPPQRPSLQKPP | 76 | A0A1B0GUS0 | |
| DVAPLPQRRNPPQQP | 401 | Q92817 | |
| ISRPAAPPEPRPQQQ | 56 | O14511 | |
| APPEPRPQQQPQPRS | 61 | O14511 | |
| ESPPPGRQPNQKTLP | 921 | Q14005 | |
| PQVQRPPRPQSPTQL | 356 | Q8WXX7 | |
| PRPNFLPQVRPKPVA | 226 | Q96BD5 | |
| APIRPPKPQSSPQTL | 106 | O95600 | |
| QKQRRAPVGPRAPPP | 21 | P0DV74 | |
| QKQRRAPVGPRAPPP | 21 | P0DV73 | |
| KIRQRQSILPPPQGP | 191 | Q9H6S3 | |
| QKQRRAPVGPRAPPP | 21 | P0DV76 | |
| QTQRSKPQPAVPPRP | 356 | A6NI72 | |
| QTQRSKPQPAVPPRP | 331 | A8MVU1 | |
| KPVPPQPSAPESRQV | 4621 | Q5VST9 | |
| QSRPGPVPVPVQPSR | 1096 | Q96JP2 | |
| QKQRRAPVGPSAPPP | 21 | A6NJQ4 | |
| RSDPGPPVPRLPQKQ | 1196 | O14559 | |
| PASQPLPRKRPPVTQ | 1881 | O95996 | |
| SPRSPRNNPVPPEAK | 776 | P32927 | |
| QQQVQPKPSPPRRTP | 671 | O15234 | |
| AAPRPPRAQQPQQPS | 96 | Q8WTW3 | |
| PPQAQPPQQRRSPAS | 181 | Q8NE35 | |
| PALQPPRRPKSSNPF | 66 | Q9Y6N1 | |
| QPRPESKPESQIPPQ | 281 | Q13283 | |
| SKPESQIPPQRPQRD | 286 | Q13283 | |
| RQRGQNKERPPPVPN | 171 | P07766 | |
| APAQPPPARKQNVGR | 2566 | O15021 | |
| KEQPPPLQPPQQSIR | 26 | Q6PJG2 | |
| RRPQKPIPPAVPQGN | 556 | Q53TQ3 | |
| RPRKQQQEPTGEPSP | 31 | P52926 | |
| PPVSRAPPQPEKLQT | 1336 | Q05BV3 | |
| RPPKLTQPPPPRNSN | 456 | Q96PD2 | |
| STTVPQPQARDKPPP | 251 | Q8IX15 | |
| QKQRRAPVGPRAPPP | 21 | A6NIJ5 | |
| KPPRPQPPPQQVRSA | 36 | P35556 | |
| QKQRRAPVGPRAPPP | 21 | A8MXJ8 | |
| QKQRRAPVGPRAPPP | 21 | P0C7X0 | |
| INKTSPPQPVNPPRP | 391 | A8MW92 | |
| NPKSRLPPSPRPQGQ | 116 | P21217 | |
| EQTPPPQPRTAQPQK | 921 | P78332 | |
| RPVNGKTIPTQQPPT | 326 | Q5HYK7 | |
| QRSPSKVKPPVRNPQ | 821 | Q13428 | |
| PPGPQVNINPRKPKR | 1706 | A0AVI2 | |
| QKQRRAPVGPRAPPP | 21 | A8MX19 | |
| QKQRRAPVGPRAPPP | 21 | A6NNJ1 | |
| QKQRRAPVGPRAPPP | 21 | P0C7W8 | |
| QKQRRAPVGPRAPPP | 21 | D6RGX4 | |
| LSQPVPRQPNKSPPG | 421 | Q86VE3 | |
| SPQRPKQQPAAPPAV | 76 | Q13875 | |
| QKQRRAPVGPRAPPP | 21 | P0C7V4 | |
| QQPQTGPRLPPRQPT | 616 | Q01826 | |
| QPPKQPQLIGRPPSA | 2406 | Q86UP3 | |
| RQQVPKPCQASPPRL | 1036 | Q96KV7 | |
| VSPRPSPTQQPRPKG | 261 | Q96BF3 | |
| QPNKPRVRPTSRQPS | 336 | O94991 | |
| RAKTQTPPVSPAPQP | 396 | Q14247 | |
| QKPPTAPPERQPQVD | 216 | O76061 | |
| RATPILQPRPQPQPQ | 126 | Q12772 | |
| QKQRRAPVGPRAPPP | 21 | Q658T7 | |
| KDPVTTGTPQPPQRR | 96 | Q9UGU0 | |
| PNSQNKPRPPPSEQR | 3836 | Q96JG9 | |
| PPSQNKPATFRPPNR | 1476 | Q07157 | |
| RTRKGPKRPQQPNPP | 106 | Q8WUA4 | |
| PKRPQQPNPPSAPLV | 111 | Q8WUA4 | |
| QQPPPPRRVTNVGSL | 6 | O00401 | |
| PRARPPVQKQASLPV | 1851 | Q9Y3S1 | |
| KPKTSPRPRIPQTQP | 536 | Q7Z7G0 | |
| LPQPNTLPPQRPKAS | 676 | Q6BDS2 | |
| PGPRPQSLPIQNIKR | 391 | Q9ULJ6 | |
| RSPQPPSRQAEPPKK | 486 | Q86VM9 | |
| QSPPPAKRPNTSPDR | 841 | Q86VM9 | |
| QKQRRAPVGPRAPPP | 21 | P0DV75 | |
| PERKQQPQLPRPPTT | 466 | Q9P206 |